Effect of Linaclotide on Quality of Life in Adults With Irritable Bowel Syndrome With Constipation: Pooled Results From Two Randomized, Double-Blind, Placebo-Controlled Phase 3 Trials

被引：0
|
作者：
Carson, Robyn
Tourkodimitris, Stavros
Lewis, Barbara E.
Johnston, Jeffrey M.
机构：
来源：
GASTROENTEROLOGY | 2011年 / 140卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S51 / S51
页数：1
相关论文
共 50 条
  • [41] A randomized, placebo-controlled, double-blind trial of paroxetine controlled release (CR) in irritable bowel syndrome
    Masand, P. S.
    Peindl, K.
    Krulewicz, S.
    Varia, I.
    Patkar, A. A.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S137 - S137
  • [42] A Nonviable Probiotic in Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study
    Mack, Isabelle
    Schwille-Kiuntke, Juliane
    Mazurak, Nazar
    Niesler, Beate
    Zimmermann, Kurt
    Moennikes, Hubert
    Enck, Paul
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (05) : 1039 - +
  • [43] Eluxadoline for the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome: Results of 2 Randomized, Double-blind, Placebo-Controlled Phase 3 Clinical Trials of Efficacy and Safety
    Lembo, Anthony
    Dove, Scott
    Andrae, David
    Davenport, J. Michael
    McIntyre, Gail
    Almenoff, June
    Covington, Paul S.
    GASTROENTEROLOGY, 2014, 146 (05) : S159 - S159
  • [44] Efficacy and Safety of Tenapanor in Patients With Constipation Predominant Irritable Bowel Syndrome: A 12-week, Double-Blind, Placebo-Controlled, Randomized Phase 3 Trial
    Chey, William D.
    Lembo, Anthony J.
    Korner, Paul
    Yan, Andrew
    Rosenbaum, David P.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S226 - S227
  • [45] The effect of phloroglucinol in diarrhea-dominant irritable bowel syndrome: randomized, double-blind, placebo-controlled trial
    Cha, B. K.
    Choi, C. H.
    Yang, S. Y.
    Song, I. D.
    Kim, S. W.
    Huh, C.
    Kim, B. J.
    Do, J. H.
    Kim, J. G.
    Chang, S. K.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 : 10 - 10
  • [46] The Effect of Phloroglucinol in Diarrhea-Dominant Irritable Bowel Syndrome: Randomized, Double-Blind, Placebo-Controlled Trial
    Cha, Bong Ki
    Choi, Chang Hwan
    Kim, Beom Jin
    Oh, Hyoung-Chul
    Kim, Jeong Wook
    Do, Jae Hyuk
    Kim, Jae G.
    Chang, Se Kyung
    GASTROENTEROLOGY, 2011, 140 (05) : S611 - S612
  • [47] Efficacy and safety of vibegron for the treatment of irritable bowel syndrome in women: Results of a randomized, double-blind, placebo-controlled phase 2 trial
    Lacy, Brian E.
    King, Jennifer
    Shortino, Denise
    Schaumburg, Chris
    Haag-Molkenteller, Cornelia
    Chey, William D.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2022, 34 (12):
  • [48] A Prospective Double-Blind Placebo-Controlled Trial of Mosapride in Patients with Constipation-predominant Irritable Bowel Syndrome
    Mansour, Nabil
    Ghaith, Ola
    El-Halabi, Mustapha
    Sharara, Ala
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 : S501 - S501
  • [49] Alverine citrate fails to relieve the symptoms of irritable bowel syndrome: results of a double-blind, randomized, placebo-controlled trial
    Mitchell, SA
    Mee, AS
    Smith, GD
    Palmer, KR
    Chapman, RW
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2002, 16 (06) : 1187 - 1195
  • [50] Lubiprostone significantly improves symptom relief rates in adults with irritable bowel syndrome and constipation (IBS-C): Data from two twelve-week, randomized, placebo-controlled, double-blind trials
    Drossman, D. A.
    Chey, W.
    Panas, R.
    Wahle, A.
    Scott, C.
    Ueno, R.
    GASTROENTEROLOGY, 2007, 132 (07) : 2586 - 2587
12345